CIK 0001534133 · Non-accelerated filer<br>Smaller reporting company
CalciMedica, Inc.
Sign in to watch- Ticker
- CALC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452120079
- Phone
- 858-952-5500
- Business address
- 505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
- Former names
- CalciMedica, Inc. /DE/, GRAYBUG VISION, INC., GRAYBUG, Inc., GRAYBUG LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-05 | Dunn Michael J. President and COO | Grant or award · Employee Stock Option (Right to Buy) | +65,124 | 65,124 | ||
| 2025-04-05 | Bardin Stephen Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +67,728 | 67,728 | ||
| 2025-04-05 | Roberts Eric W CHIEF BUSINESS OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +83,358 | 83,358 | ||
| 2025-04-05 | Leheny A. Rachel CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +148,482 | 148,482 | ||
| 2025-01-15 | Glicklich Alan Director | Grant or award · Director Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2024-12-06 | MIDDLETON FRED A Director | Purchase | +4,800 | $2.65 | $13K | 36,514 |
| 2024-11-01 | Sanderling Venture Partners VI Co Investment Fund LP 10% owner | Purchase | +86,867 | $3.75 | $326K | 814,300 |
| 2024-11-01 | Sanderling Venture Partners VI Co Investment Fund LP 10% owner | Purchase | +877 | $3.75 | $3K | 22,479 |
| 2024-11-01 | MIDDLETON FRED A Director | Purchase | +20,000 | $3.75 | $75K | 31,714 |
| 2024-11-01 | MIDDLETON FRED A Director | Purchase | +86,867 | $3.75 | $326K | 814,300 |
| 2024-11-01 | MIDDLETON FRED A Director | Purchase | +877 | $3.75 | $3K | 22,479 |
| 2024-11-01 | Leheny A. Rachel CHIEF EXECUTIVE OFFICER | Purchase | +20,000 | $3.75 | $75K | 130,926 |
| 2024-11-01 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +53,333 | $3.75 | $200K | 164,706 |
| 2024-11-01 | WILSON ROBERT N Director | Purchase | +53,333 | $3.75 | $200K | 417,529 |
| 2024-09-09 | Dunn Michael J. President and COO | Option exercise | +11,761 | $1.39 | $16K | 11,761 |
| 2024-09-09 | Dunn Michael J. President and COO | Option exercise · Employee Stock Option (Right to Buy) | −11,761 | 0 | ||
| 2024-08-27 | Guerard Frederic Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-08-27 | BJERKHOLT ERIC Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-08-27 | Shaw Allan Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-08-27 | MIDDLETON FRED A Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 6 of 29 · 565 trades